在唐氏综合征中特征化粉样蛋白和陶负担的出现
Matthew D Zammit1, Tobey J Betthauser2,3, Andrew K McVea1
1University of Wisconsin-Madison Waisman Center, Madison, Wisconsin, USA.
概括
患有唐氏综合征 (DS) 的个人经历了快速的粉样蛋白积累和早期的陶氏体增加,这对于了解阿尔茨海默病 (AD) 在这个人群中的进展至关重要.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
背景情况:
- 患有唐氏综合征 (DS) 的人始终会发展出阿尔茨海默氏症 (AD) 神经病理学.
- 了解AD生物标志物进展对于DS特异性治疗和解释药物疗效至关重要.
研究的目的:
- 在成年人中模拟粉样β (Aβ) 和生物标志物轨迹.
- 建立特定于唐氏综合征的AD神经病理进展时间表.
主要方法:
- 177名患有DS的成年人接受了PET和MR成像.
- 模拟了粉样β (Aβ) 阳性 (A+) 慢性.
- 纵向的变化与A+慢性性相比较.
主要成果:
- 在A+之后,在所有神经纤维质 (NFT) 区域观察到升高的TAU.
- 随着A+慢性增长而增加,在NFT区域I-III中早期增加 (0-2.5年).
- 几乎所有A+个体都在中叶显示出tau的增加.
结论:
- 在DS中,粉样蛋白的积累是快速的.
- 陶氏病理的发病时间相对于粉样蛋白的发病时间较早.
- 建立了一个时间模型的AD进展在DS,独立于时间的年龄.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517


